startup.bid
NO
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

dNovo

The cure for hair loss.

Nedlagt

Om selskapet

Selskapsbeskrivelse på engelsk

At dNovo, we are curing hair loss by creating new hair, de novo. We are doing this with cellular reprogramming technology that we pioneered at Stanford and Harvard. With this technology, we can take any patient derived cell, whether it be blood, skin or fat and reprogram (convert) them into medically relevant cell types. Our first objective is to cure hair loss by using our reprogramming technology to make new hair (patent pending). This is different from everything currently available on the market because the hair loss industry is focused on maintaining the hair that you already have, but no one is trying to produce NEW hair, de novo. After hair, we envision using our cellular reprogramming technique to make any cell, any tissue or any organ on demand to replace what is lost as we age.

Emner

Anti-AgingHealthcareTherapeutics
Sted
San Francisco, CA, USA
Teamstørrelse
4 ansatte
YC-kull
Summer 2018
Status
Nedlagt
Fase
Tidlig fase

Lignende startups og konkurrenter

Spørsmål og svar

Hvor holder dNovo til?

San Francisco, CA, USA

Hvor mange jobber i dNovo?

Antall ansatte ifølge selskapsprofilen: 4.

Har dNovo hentet kapital?

Det finnes ingen investeringsrunder for dNovo i våre data.

Hvilke alternativer finnes til dNovo?

Lignende startups: Forever Labs, SFA Therapeutics og Rejuvenation Technologies Inc.